124 results on '"Bárdi, Edit"'
Search Results
2. Radiation Doses Received by Major Organs at Risk in Children and Young Adolescents Treated for Cancer with External Beam Radiation Therapy: A Large-scale Study from 12 European Countries
3. From long-term follow-up Recommendations for clinical practice to plain language summaries for childhood, adolescent, and young adult cancer survivors
4. Scaling up and implementing the digital Survivorship Passport tool in routine clinical care – The European multidisciplinary PanCareSurPass project
5. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
6. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
7. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
8. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
9. Late Adverse Effects after Treatment for Childhood Acute Leukemia
10. Guidance to Bone Morbidity in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
11. Childhood leukemia and non-Hodgkin lymphoma survivors lack of knowledge about their past disease and possible late effects. I-BFM ELTEC study with Chilean and Croatian participation
12. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries
13. Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group
14. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
15. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
16. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group
17. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe
18. Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study
19. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
20. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
21. Value of FDG-PET/CT Examinations in Different Cancers of Children, Focusing on Lymphomas
22. Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
23. Anthracycline Causes Impaired Vascular Endothelial Function and Aortic Stiffness in Long Term Survivors of Childhood Cancer
24. Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer
25. Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin’s lymphoma
26. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study
27. Cystatin C is a suitable marker of glomerular function in children with cancer
28. Polymorphism of Angiotensin Converting Enzyme Is Associated With Severe Circulatory Compromise in Febrile Neutropenic Children With Cancer
29. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study.
30. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup
31. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
32. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
33. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe
34. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors
35. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
36. Életminőséget befolyásoló késői mellékhatások komplex felmérése: a debreceni modell
37. Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care
38. Preliminary results in the treatment of pediatric medulloblastoma/PNET with the Hungarian MBL2004 protocol
39. Use Of FDG-PET CT for Staging and Follow Up in Children with Different Cancers
40. Protection of glomerular and tubular function by theophylline in children with cancer
41. Osteoporosis in children with cancer
42. Late effects on renal glomerular and tubular function in childhood cancer survivors
43. Value of FDG-PET/CT Examinations in Different Cancers of Children, Focusing on Lymphomas
44. Anthracycline Causes Impaired Vascular Endothelial Function and Aortic Stiffness in Long Term Survivors of Childhood Cancer
45. Late effects on renal glomerular and tubular function in childhood cancer survivors
46. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
47. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup
48. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
49. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries
50. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.